Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 497 (miR-497) is a small non-coding RNA molecule (~22 nucleotides) encoded by the first intron of the MIR497HG gene on chromosome 17p13.1. As a member of the highly conserved miR-15/16/195/424/497 family, miR-497 functions in post-transcriptional gene silencing by binding to the 3′-untranslated region (3′UTR) of target mRNAs through its seed sequence (AGCAGCA), thereby reducing mRNA stability or inhibiting translation. miR-497 is expressed in normal tissues but is frequently dysregulated in multiple cancers, most commonly downregulated and acting as a tumor suppressor, though it can act as an oncogene in particular contexts such as gliomas. Its biological functions include inhibition of cell proliferation, induction of apoptosis, cell cycle arrest, anti-angiogenesis, and modulation of invasion and metastasis. Therapeutically, miR-497 is being explored as a target for cancer treatment and as a non-invasive biomarker for patient selection and efficacy monitoring. However, its pleiotropic roles and complex gene network interactions present safety and specificity challenges for clinical application.
Suppression of target mRNA translation (by binding to 3′UTR); Destabilization of target mRNA; Direct modulation of tumor suppressor or oncogene pathways via gene targeting; Modulation of signaling pathways (e.g., PI3K/AKT and MAPK/ERK via IRS1 suppression)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 497 (miR-497).